Special Diabetes Program: Funding Opportunities Archive

These funding opportunities are closed. They are supported in whole or in part by the Special Statutory Funding Program for Type 1 Diabetes Research. For information on the scientific accomplishments resulting from these opportunities, please see Reports and Planning.

View current research funding opportunities supported by the Special Diabetes Program.

1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017

2017

Limited Competition: Follow-up on Subjects and Immunological Assessments in The Environmental Determinants of Diabetes in the Young Study (TEDDY) (UC4)
RFA-DK-17-508
Posted Date: April 26, 2017
Open Date (Earliest Submission Date): June 14, 2017
Letter of Intent Due Date: June 14, 2017
Application Receipt Date: July 14, 2017 by 5:00PM local time of applicant organization

Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)
RFA-DK-17-507
Posted Date: April 21, 2017
Open Date (Earliest Submission Date): June 14, 2017
Letter of Intent Due Date: June 14, 2017
Application Receipt Date: July 14, 2017 by 5:00PM local time of applicant organization

Limited Competition: Follow-up on Subjects and Immunological Assessments in The Environmental Determinants of Diabetes in the Young Study (TEDDY) (UC4)
RFA-DK-16-504
Posted Date: December 15, 2016
Open Date (Earliest Submission Date): February 15, 2017
Letter of Intent Due Date: February 15, 2017
Application Receipt Date: March 15, 2017 by 5:00PM local time of applicant organization

Competitive Collaborative Projects for Human Islet Biology (UC4)
RFA-DK-17-004
Posted Date: December 14, 2016
Open Date (Earliest Submission Date): February 23, 2017
Letter of Intent Due Date: February 23, 2017
Application Receipt Date: March 23, 2017 by 5:00PM local time of applicant organization

Therapeutic Targeting of The Human Islet Environment (UC4)
RFA-DK-17-003
Posted Date: December 14, 2016
Open Date (Earliest Submission Date): February 22, 2017
Letter of Intent Due Date: February 22, 2017
Application Receipt Date: March 22, 2017 by 5:00PM local time of applicant organization

Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)
RFA-DK-16-505
Posted Date: December 5, 2016
Open Date (Earliest Submission Date): February 14, 2017
Letter of Intent Due Date: February 14, 2017
Application Receipt Date: March 14, 2017 by 5:00PM local time of applicant organization

Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)
RFA-DK-16-506
Posted Date: December 1, 2016
Open Date (Earliest Submission Date): February 2, 2017
Letter of Intent Due Date: February 2, 2017
Application Receipt Date: March 2, 2017 by 5:00PM local time of applicant organization

2016

Neurocognitive Effects of Glycemic Dysregulation in Type 1 Diabetes (DP3)
RFA-DK-16-007
Posted Date: June 15, 2016
Open Date (Earliest Submission Date): October 14, 2016
Letter of Intent Due Date: October 14, 2016
Application Receipt Date: November 14, 2016 by 5:00PM local time of applicant organization

Limited Competition for the Continuation of The Collaborative Islet Transplantation Registry (UC4)
RFA-DK-16-503
Posted Date: June 14, 2016
Open Date (Earliest Submission Date): October 21, 2016
Letter of Intent Due Date: October 21, 2016
Application Receipt Date: November 21, 2016 by 5:00PM local time of applicant organization

Standardization of C-peptide and HbA1c Measurements Program (UC4)
RFA-DK-16-011
Posted Date: May 23, 2016
Open Date (Earliest Submission Date): October 22, 2016
Letter of Intent Due Date: October 22, 2016
Application Receipt Date: November 22, 2016 by 5:00PM local time of applicant organization

Human Islet Distribution Coordinating Center (UC4)
RFA-DK-16-023
Posted Date: March 31, 2016
Open Date (Earliest Submission Date): October 22, 2016
Letter of Intent Due Date: October 22, 2016
Application Receipt Date: November 22, 2016 by 5:00PM local time of applicant organization

Study to Assess the Incidence of Type 1 Diabetes in Young Adults (U18)
RFA-DP-16-005
Posted Date: December 18, 2015
Open Date (Earliest Submission Date): December 18, 2015
Letter of Intent Due Date: January 22, 2016
Application Receipt Date: February 23, 2016 by 5:00PM local time of applicant organization

Improving Diabetes Management in Children with Type 1 Diabetes (DP3)
RFA-DK-16-003
Posted Date: December 8, 2015
Open Date (Earliest Submission Date): May 22, 2016
Letter of Intent Due Date: May 22, 2016
Application Receipt Date: June 22, 2016 by 5:00PM local time of applicant organization

Understanding Barriers and Facilitators to Type 1 Diabetes Management in Adults (DP3)
RFA-DK-16-002
Posted Date: December 8, 2015
Open Date (Earliest Submission Date): May 22, 2016
Letter of Intent Due Date: May 22, 2016
Application Receipt Date: June 22, 2016 by 5:00PM local time of applicant organization

Improving Diabetes Management in Pre-teens, Adolescents and/or Young Adults with Type 1 Diabetes (DP3)
RFA-DK-16-001
Posted Date: December 8, 2015
Open Date (Earliest Submission Date): May 22, 2016
Letter of Intent Due Date: May 22, 2016
Application Receipt Date: June 22, 2016 by 5:00PM local time of applicant organization

Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44)
RFA-DK-16-004
Posted Date: November 19, 2015
Open Date (Earliest Submission Date): May 28, 2016
Letter of Intent Due Date: May 28, 2016
Application Receipt Date: June 28, 2016 by 5:00PM local time of applicant organization

Human Pancreas Procurement and Analysis Program (HPPAP) (UC4)
RFA-DK-15-027
Posted Date: October 29, 2015
Open Date (Earliest Submission Date): February 3, 2016
Letter of Intent Due Date: February 3, 2016
Application Receipt Date: March 3, 2016 by 5:00PM local time of applicant organization

Research Using Biosamples and Subjects from Type 1 Diabetes Clinical Studies--Complications (DP3)
RFA-DK-15-019
Posted Date: October 8, 2015
Open Date (Earliest Submission Date): February 3, 2016
Letter of Intent Due Date: February 3, 2016
Application Receipt Date: March 3, 2016 by 5:00PM local time of applicant organization

Limited Competition: Understanding How Epigenetics and Infections Impact Autoimmunity and Diabetes in The Environmental Determinants of Diabetes in the Young Study (TEDDY) (UC4)
RFA-DK-15-506
Posted Date: October 2, 2015
Open Date (Earliest Submission Date): February 3, 2016
Letter of Intent Due Date: February 3, 2016
Application Receipt Date: March 3, 2016 by 5:00PM local time of applicant organization

Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (DP3)
RFA-DK-15-028
Posted Date: September 24, 2015
Open Date (Earliest Submission Date): February 3, 2016
Letter of Intent Due Date: February 3, 2016
Application Receipt Date: March 3, 2016 by 5:00PM local time of applicant organization

Clinical, Behavioral and Physiological Research Testing Current and Novel Closed Loop Systems (DP3)
RFA-DK-16-009
Posted Date: September 18, 2015
Open Date (Earliest Submission Date): May 28, 2016
Letter of Intent Due Date: May 28, 2016
Application Receipt Date: June 28, 2016 by 5:00PM local time of applicant organization

Advanced Clinical Trials to Test Artificial Pancreas Device Systems in Type 1 Diabetes (UC4)
RFA-DK-16-008
Posted Date: September 2, 2015
Open Date (Earliest Submission Date): February 9, 2016
Letter of Intent Due Date: February 9, 2016
Application Receipt Date: March 9, 2016 by 5:00PM local time of applicant organization

Type 1 Diabetes Pathfinder Award (DP2)
RFA-DK-15-030
Posted Date: July 29, 2015
Open Date (Earliest Submission Date): January 17, 2016
Letter of Intent Due Date: January 17, 2016
Application Receipt Date: February 17, 2016 by 5:00PM local time of applicant organization

Mechanisms Underlying the Contribution of Type 1 Diabetes Risk-Associated Variants (DP3)
RFA-DK-15-025
Posted Date: July 7, 2015
Open Date (Earliest Submission Date): January 17, 2016
Letter of Intent Due Date: January 17, 2016
Application Receipt Date: February 17, 2016 by 5:00PM local time of applicant organization

2015

Understanding the Pathogenesis and Etiology of Type 1 Diabetes Using Biosamples and Subjects from Clinical Studies (DP3)
RFA-DK-15-018
Posted Date: August 4, 2015
Open Date (Earliest Submission Date): October 12, 2015
Letter of Intent Due Date: October 12, 2015
Application Receipt Date: November 12, 2015 by 5:00PM local time of applicant organization

Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (T1D) (R43/R44)
RFA-DK-15-024
Posted Date: July 28, 2015
Open Date (Earliest Submission Date): October 18, 2015
Letter of Intent Due Date: October 18, 2015
Application Receipt Date: November 18, 2015 by 5:00PM local time of applicant organization

Small Business Innovation Research (SBIR) to Develop New or Improved Closed Loop Automated Technologies for Diabetes Therapy and Monitoring (R43/R44)
RFA-DK-15-022
Posted Date: July 24, 2015
Open Date (Earliest Submission Date): October 18, 2015
Letter of Intent Due Date: October 18, 2015
Application Receipt Date: November 18, 2015 by 5:00PM local time of applicant organization

Career Development Programs in Diabetes Research for Pediatric Endocrinologists (K12)
RFA-DK-15-006
Posted Date: April 21, 2015
Open Date (Earliest Submission Date): November 2, 2015
Letter of Intent Due Date: November 2, 2015
Application Receipt Date: December 3, 2015 by 5:00PM local time of applicant organization

Limited Competition for the Continuation of the SEARCH for Diabetes in Youth Cohort Study (UC4)
RFA-DK-14-508
Posted Date: September 30, 2014
Open Date (Earliest Submission Date): February 10, 2015
Letter of Intent Due Date: February 10, 2015
Application Receipt Date: March 10, 2015 by 5:00PM local time of applicant organization

Consortium on Beta-cell Death and Survival (HIRN-CBDS) (UC4)
RFA-DK-14-021
Posted Date: August 27, 2014
Open Date (Earliest Submission Date): February 3, 2015
Letter of Intent Due Date: February 3, 2015
Application Receipt Date: March 3, 2015 by 5:00PM local time of applicant organization

Type 1 Diabetes Complications IMPACT Award (DP3)
RFA-DK-14-017
Posted Date: August 26, 2014
Open Date (Earliest Submission Date): February 19, 2015
Letter of Intent Due Date: February 19, 2015
Application Receipt Date: March 19, 2015 by 5:00PM local time of applicant organization

Advanced Clinical Trials to Test Artificial Pancreas Device Systems in Type 1 Diabetes (UC4)
RFA-DK-14-024
Posted Date: June 21, 2014 Open Date (Earliest Submission Date): March 15, 2015
Letter of Intent Due Date: March 15, 2015
Application Receipt Date: April 15, 2015 by 5:00PM local time of applicant organization

Improving Diabetes Management in Young Children with Type 1 Diabetes (DP3)
RFA-DK-14-022
Posted Date: June 19, 2014
Open Date (Earliest Submission Date): February 18, 2015
Letter of Intent Due Date: February 18, 2015
Application Receipt Date: March 18, 2015 by 5:00PM local time of applicant organization

2014

Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)
RFA-DK-14-507
Posted Date: August 20, 2014
Open Date (Earliest Submission Date): November 3, 2014
Letter of Intent Due Date: November 3, 2014
Application Receipt Date: December 3, 2014 by 5:00PM local time of applicant organization

Type 1 Diabetes TrialNet Clinical Centers (U01)
RFA-DK-14-016
Posted Date: August 15, 2014
Open Date (Earliest Submission Date): November 3, 2014
Letter of Intent Due Date: November 3, 2014
Application Receipt Date: December 3, 2014 by 5:00PM local time of applicant organization

Limited Competition: Data Coordinating Center for The Environmental Determinants of Diabetes in the Young (TEDDY) Study (UC4)
RFA-DK-14-505
Posted Date: June 25, 2014 Open Date (Earliest Submission Date): November 2, 2014
Letter of Intent Due Date: November 2, 2014
Application Receipt Date: December 2, 2014 by 5:00PM local time of applicant organization

Research Using Subjects From Selected Type 1 Diabetes Clinical Studies (Living Biobank) (DP3)
PAR-14-258
Posted Date: June 11, 2014
Open Date (Earliest Submission Date): October 20, 2014
Letter of Intent Due Date: October 20, 2014
Application Receipt Date: November 20, 2014 by 5:00PM local time of applicant organization

Research Using Biosamples from Selected Type 1 Diabetes Clinical Studies (DP3)
PAR-14-257
Posted Date: June 10, 2014
Open Date (Earliest Submission Date): October 20, 2014
Letter of Intent Due Date: October 20, 2014
Application Receipt Date: November 20, 2014 by 5:00PM local time of applicant organization

Diabetes Impact Award-Closed Loop Technologies: Development and Integration of Novel Components for an Automated Artificial Pancreas System (DP3)
RFA-DK-14-015
Posted Date: May 14, 2014
Open Date (Earliest Submission Date): October 24, 2014
Letter of Intent Due Date: October 24, 2014
Application Receipt Date: November 24, 2014 by 5:00PM local time of applicant organization

Diabetes Impact Award-Closed Loop Technologies: Clinical, Physiological and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (DP3)
RFA-DK-14-014
Posted Date: May 14, 2014 Open Date (Earliest Submission Date): October 24, 2014
Letter of Intent Due Date: October 24, 2014
Application Receipt Date: November 24, 2014 by 5:00PM local time of applicant organization

Small Business Technology Transfer Research (STTR) to Develop New Diagnostic, Monitoring and Therapeutics Technologies for the Complications of Type 1 Diabetes (T1D) [STTR (R41/R42]
PA-14-059
Posted Date: January 3, 2014
Open Date (Earliest Submission Date): March 5, 2014
Letter of Intent Due Date: Not applicable
Expiration Date: January 8, 2017

Small Business Innovation Research (SBIR) to Develop New Diagnostic, Monitoring and Therapeutics Technologies for the Complications of Type 1 Diabetes (T1D) [STTR (R43/R44]
PA-14-058
Posted Date: January 3, 2014
Open Date (Earliest Submission Date): March 5, 2014
Letter of Intent Due Date: Not applicable
Expiration Date: January 8, 2017

Research Using Biosamples from Selected Type 1 Diabetes Clinical Studies (DP3)
PAR-14-065
Posted Date: January 7, 2013
Open Date (Earliest Submission Date): March 10, 2014
Letter of Intent Due Date: March 10, 2014
Application Receipt Date: April 10, 2014 by 5:00PM local time of applicant organization

Research Using Subjects From Selected Type 1 Diabetes Clinical Studies (Living Biobank) (DP3)
PAR-14-064
Posted Date: January 7, 2013
Open Date (Earliest Submission Date): March 10, 2014
Letter of Intent Due Date: March 10, 2014
Application Receipt Date: April 10, 2014 by 5:00PM local time of applicant organization

Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D): Towards an Artificial Pancreas (SBIR) (R43/R44)
RFA-DK-13-028
Posted Date: December 4, 2013
Open Date (Earliest Submission Date): February 14, 2014
Letter of Intent Due Date: February 14, 2014
Application Receipt Date: March 14, 2014 by 5:00PM local time of applicant organization

Biomarkers for Diabetes Complications - Non-Invasive Measures in the Eye (DP3)
RFA-DK-13-027
Posted Date: November 6, 2013
Open Date (Earliest Submission Date): March 7, 2014
Letter of Intent Due Date: March 7, 2014
Application Receipt Date: April 7, 2014 by 5:00PM local time of applicant organization

Human Islet Research Network (HIRN) Coordinating Center (U01)
RFA-DK-13-013
Posted Date: September 26, 2013
Open Date (Earliest Submission Date): January 27, 2014
Letter of Intent Due Date: January 27, 2014
Application Receipt Date: February 27, 2014 by 5:00PM local time of applicant organization

Human Islet Research Network Bioinformatics Center (HIRN-BC) (U01)
RFA-DK-13-014
Posted Date: September 26, 2013
Open Date (Earliest Submission Date): January 27, 2014
Letter of Intent Due Date: January 27, 2014
Application Receipt Date: February 27, 2014 by 5:00PM local time of applicant organization

Consortium on Targeting and Regeneration (HIRN-CTAR) (UC4)
RFA-DK-13-015
Posted Date: September 26, 2013
Open Date (Earliest Submission Date): January 27, 2014
Letter of Intent Due Date: January 27, 2014
Application Receipt Date: February 27, 2014 by 5:00PM local time of applicant organization

Consortium on Human Islet Biomimetics (HIRN-CHIB) (UC4)
RFA-DK-13-016 Posted Date: September 26, 2013
Open Date (Earliest Submission Date): January 27, 2014
Letter of Intent Due Date: January 27, 2014
Application Receipt Date: February 27, 2014 by 5:00PM local time of applicant organization

Consortium on Modeling Autoimmune Interactions (HIRN-CMAI) (UC4)
RFA-DK-13-017
Posted Date: September 26, 2013
Open Date (Earliest Submission Date): January 27, 2014
Letter of Intent Due Date: January 27, 2014
Application Receipt Date: February 27, 2014 by 5:00PM local time of applicant organization

Consortium on Beta-cell Death and Survival (HIRN-CBDS) (UC4)
RFA-DK-13-018
Posted Date: September 26, 2013
Open Date (Earliest Submission Date): January 27, 2014
Letter of Intent Due Date: January 27, 2014
Application Receipt Date: February 27, 2014 by 5:00PM local time of applicant organization

Harvesting the Neuroimaging Cornucopia for Pancreatic Islet Imaging Reagents for Diabetes Research (DP3)
RFA-DK-13-024
Posted Date: September 13, 2013
Open Date (Earliest Submission Date): January 20, 2014
Letter of Intent Due Date: January 20, 2014
Application Receipt Date: February 20, 2014 by 5:00PM local time of applicant organization

Improving Diabetes Management in Young Children with Type 1 Diabetes (DP3)
RFA-DK-13-022
Posted Date: August 9, 2013
Open Date (Earliest Submission Date): January 19, 2014
Letter of Intent Due Date: January 19, 2014
Application Receipt Date: February 19, 2014 by 5:00PM local time of applicant organization

Understanding Barriers and Facilitators to Type 1 Diabetes Management in Adults (DP3)
RFA-DK-13-023
Posted Date: August 9, 2013
Open Date (Earliest Submission Date): January 19, 2014
Letter of Intent Due Date: January 19, 2014
Application Receipt Date: February 19, 2014 by 5:00PM local time of applicant organization

2013

Type 1 Diabetes TrialNet Clinical Network Hub (U01)
RFA-DK-13-009
Posted Date: June 18, 2013
Open Date (Earliest Submission Date): October 27, 2013
Letter of Intent Due Date: October 27, 2013
Application Receipt Date: November 27, 2013, by 5:00 PM local time of applicant organization

Type 1 Diabetes TrialNet Clinical Centers (U01)
RFA-DK-13-010
Posted Date: June 18, 2013
Open Date (Earliest Submission Date): October 27, 2013
Letter of Intent Due Date: October 27, 2013
Application Receipt Date: November 27, 2013, by 5:00 PM local time of applicant organization

Bioengineering Interdisciplinary Training for Diabetes Research (T32)
PAR-13-047
Posted Date: December 17, 2012
Open Date (Earliest Submission Date): February 7, 2013
Letter of Intent Due Dates February 7, 2013 and October 26, 2013
Application Receipt Date: March 7, 2013 and November 26, 2013, by 5:00 PM local time of applicant organization

Diabetes Impact Award-Closed Loop Technologies: Clinical, Physiological and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (DP3)
RFA-DK-12-020
Posted Date: December 12, 2012
Open Date (Earliest Submission Date): February 28, 2013
Letter of Intent Due Date: February 28, 2013
Application Receipt Date: March 28, 2013 by 5:00PM local time of applicant organization

Diabetes Impact Award-Closed Loop Technologies: Development and Integration of Novel Components for an Automated Artificial Pancreas System (DP3)
RFA-DK-12-021
Posted Date: December 12, 2012
Open Date (Earliest Submission Date): February 28, 2013
Letter of Intent Due Date: February 28, 2013
Application Receipt Date: March 28, 2013 by 5:00PM local time of applicant organization

Research Using Subjects From Selected Type 1 Diabetes Clinical Studies (Living Biobank) (DP3)
PAR-13-028
Posted Date: November 27, 2012
Open Date (Earliest Submission Date): March 2, 2013
Letter of Intent Due Date: March 2, 2013
Application Receipt Date: April 2, 2013, by 5:00 PM local time of applicant organization

Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3)
PAR-13-013
Posted Date: October 30, 2012
Open Date (Earliest Submission Date): March 2, 2013
Letter of Intent Due Date: March 2, 2013
Application Receipt Date: April 2, 2013, by 5:00 PM local time of applicant organization

Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artifical Pancreas [SBIR (R43/R44)]
RFA-DK-13-001
Posted Date: December 17, 2012
Open Date (Earliest Submission Date): February 6, 2013
Letter of Intent Due Date: February 6, 2013
Application Receipt Date: March 6, 2013 by 5:00PM local time of applicant organization

Collaborative Network for Clinical Research on Immune Tolerance (UM1)
RFA-AI-12-043
Posted Date: November 5, 2012
Letter of Intent Due Date: February 7, 2013
Application Receipt Date: March 7, 2013

2012

Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3)
PAR-11-350
Posted Date: September 28, 2011
Open Date (Earliest Submission Date): November 7, 2011
Letter of Intent Due Date: November 7, 2011; May 7, 2012
Application Receipt Date: December 7, 2011 and June 7, 2012 by 5:00 PM local time of applicant organization

Research Using Subjects From The Type 1 Diabetes TrialNet Natural History Study (Living Biobank) (DP3)
PAR-11-349
Posted Date: September 27, 2011
Open Date (Earliest Submission Date): November 7, 2011
Letter of Intent Due Date: November 7, 2011; May 7, 2012
Application Receipt Date: December 7, 2011 and June 7, 2012 by 5:00 PM local time of applicant organization

Bioengineering Interdisciplinary Training and Education for Type I Diabetes Research (T90/R90)
RFA-DK-11-023
Posted Date: November 16, 2011
Open Date (Earliest Submission Date): February 14, 2012
Letter of Intent Due Date: February 14, 2012
Application Receipt Date: March 14, 2012 by 5:00 PM local time of applicant organization

The Human Islet Distribution Coordinating Center (UC4)
RFA-DK-12-001
Posted Date: March 7, 2012
Open Date (Earliest Submission Date): April 16, 2012
Letter of Intent Due Date: April 16, 2012
Application Receipt Date: May 16, 2012 by 5:00 PM local time of applicant organization

The Collaborative Islet Transplantation Registry (UC4)
RFA-DK-12-002
Posted Date: March 2, 2012
Open Date (Earliest Submission Date): April 16, 2012
Letter of Intent Due Date: April 16, 2012
Application Receipt Date: May 16, 2012 by 5:00 PM local time of applicant organization

Diabetic Complications Consortium Pilot & Feasibility Proposals
Application Receipt Date: May 17, 2012

2011

Type 1 Diabetes Mouse Resource (UC4)
RFA-DK-11-031
Posted Date: October 24, 2011
Open Date (Earliest Submission Date): February 15, 2012
Letter of Intent Due Date: February 15, 2012
Application Receipt Date: March 14, 2012, by 5:00 PM local time of applicant organization

Diabetes Research Training for Behavioral Scientists (T32)
RFA-DK-11-027
Posted Date: November 1, 2011
Open Date (Earliest Submission Date): February 2, 2012
Letter of Intent Due Date: February 2, 2012
Application Receipt Date: March 2, 2012 by 5:00 PM local time of applicant organization

Career Development Programs in Diabetes Research for Behavioral Scientists (K12)
RFA-DK-11-028
Posted Date: November 1, 2011
Open Date (Earliest Submission Date): February 2, 2012
Letter of Intent Due Date: February 2, 2012
Application Receipt Date: March 2, 2012 by 5:00 PM local time of applicant organization

Improving Adherence in Pre-teens, Adolescents and Young Adults with Type 1 Diabetes (DP3)
RFA-DK-11-029
Posted Date: November 1, 2011
Open Date (Earliest Submission Date): February 2, 2012
Letter of Intent Due Date: February 2, 2012
Application Receipt Date: March 2, 2012 by 5:00 PM local time of applicant organization

Function of Type 1 Diabetes Genes (DP3)
RFA-DK-11-019
Posted Date: October 3, 2011
Open Date (Earliest Submission Date): January 29, 2012
Letter of Intent Due Date: February 1, 2012
Application Receipt Date: February 29, 2012 by 5:00 PM local time of applicant organization

Small Business Innovation Research to Develop New Methods and Technologies able to Identify Individuals at Risk of Developing Type 1 Diabetes [T1D] (R43)
RFA-DK-11-024
Posted Date: September 21, 2011
Open Date (Earliest Submission Date): November 22, 2011
Letter of Intent Due Date: November 22, 2011
Application Receipt Date: December 22, 2011 by 5:00 PM local time of applicant organization

Nonhuman Primate Islet/Kidney Transplantation Tolerance (U01)
RFA-AI-11-039
Posted Date: August 17, 2011
Open Date (Earliest Submission Date): November 14, 2011
Letter of Intent Due Date: November 14, 2011
Application Receipt Date: December 14, 2011 by 5:00 PM local time of applicant organization

Nonhuman Primate Islet/Kidney Transplantation Tolerance (U19)
RFA-AI-11-040
Posted Date: August 17, 2011
Letter of Intent Due Date: November 14, 2011
Application Receipt Date: December 14, 2011 by 5:00 PM local time of applicant organization

Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas [(SBIR) (R43/R44)]
RFA-DK-11-018
Posted Date: September 20, 2011
Open Date (Earliest Submission Date): October 23, 2011
Letter of Intent Due Date: October 26, 2011
Application Receipt Date: November 23, 2011 by 5:00 PM local time of applicant organization

Standardization of C-Peptide and HbA1C (UC4)
RFA-DK-11-020
Posted Date: August 9, 2011
Open Date (Earliest Submission Date): October 20, 2011
Letter of Intent Due Date: October 20, 2011
Application Receipt Date: November 17, 2011 by 5:00 PM local time of applicant organization

Cooperative Study Group for Autoimmune Disease Prevention (U01)
RFA-AI-11-034
Posted Date: June 17, 2011
Open Date (Earliest Submission Date): September 7, 2011
Letter of Intent Due Date: October 7, 2011
Application Receipt Date: November 8, 2011 by 5:00 PM local time of applicant organization

Clinical Trial Planning Grants in Type 1 Diabetes (R34)
RFA-DK-11-010
Posted Date: May 2, 2011
Open Date (Earliest Submission Date): February 15, 2012
Letter of Intent Due Date: February 16, 2012
Application Receipt Date: March 15, 2012 by 5:00 PM local time of applicant organization

Career Development Programs in Diabetes Research for Pediatric Endocrinologists (K12)
RFA-DK-11-006
Posted Date: February 28, 2011
Open Date (Earliest Submission Date): March 28, 2011
Letter of Intent Due Date: March 28, 2011
Application Receipt Date: April 28, 2011, by 5:00 PM local time of applicant organization

Feasibility Studies for Clinical Trials in Type 1 Diabetes (R03)
RFA-DK-11-007
Posted Date: February 4, 2011
Open Date (Earliest Submission Date): March 4, 2011
Letter of Intent Due Date: March 8, 2011
Application Receipt Date: April 4, 2011, by 5:00 PM local time of applicant organization

Type 1 Diabetes Impact Award (DP3)
RFA-DK-10-012
Posted Date: September 16, 2010
Open Date (Earliest Submission Date): February 11, 2011
Letter of Intent Due Date: February 11, 2011
Application Receipt Date: March 11, 2011, by 5:00 PM local time of applicant organization

2010

Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D). Towards an Artificial Pancreas [(SBIR) (R43/R44)]
RFA-DK-10-008
Posted Date: May 19, 2010
Open Date (Earliest Submission Date): October 29, 2010
Letter of Intent Due Date: November 1, 2010
Application Receipt Date: November 29, 2010

Animal Models of Diabetic Complications Consortium (AMDCC) Pilot and Feasibility Opportunities
Application Receipt Date: May 3, 2010

2009

Innovative Patient Outreach Programs and Ocular Screening Technologies to Improve Detection of Diabetic Retinopathy (SBIR [R43/R44])
RFA-EY-09-001
Posted Date: December 9, 2008
Open Date (Earliest Submission Date): February 23, 2009
Application Receipt Date: March 23, 2009; December 23, 2009

Beta Cell Biology Consortium (U01)
RFA-DK-09-011
Posted Date: August 14, 2009
Letter of Intent Due Date: October 26, 2009
Application Receipt Date: November 23, 2009

Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D). Towards an Artificial Pancreas (SBIR) [R43/R44])
RFA-DK-09-001
Posted Date: December 10, 2008
Open Date (Earliest Submission Date): March 15, 2009
Letter of Intent Due Date: March 16, 2009
Application Receipt Date: April 15, 2009

Fine Mapping and Function of Genes for Type 1 Diabetes (DP3)
RFA-DK-08-006
Posted Date: October 16, 2008
Open Date (Earliest Submission Date): February 27, 2009
Letter of Intent Due Date: February 27, 2009
Application Receipt Date: March 30, 2009

Limited Competition: Continuation of the Clinical Islet Transplantation (CIT) Consortium (U01)
RFA-DK-09-501
Posted Date: January 13, 2009
Application Receipt Date: March 19, 2009

Closed Loop Technologies: Clinical and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (R01)
RFA-DK-08-012
Posted Date: November 28, 2008
Open Date (Earliest Submission Date): February 19, 2009
Letter of Intent Due Date: February 19, 2009
Application Receipt Date: March 19, 2009

Closed Loop Technologies: Pilot and Exploratory Clinical and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (R21)
RFA-DK-08-013
Posted Date: November 28, 2008
Open Date (Earliest Submission Date): February 19, 2009
Letter of Intent Due Date: February 19, 2009
Application Receipt Date: March 19, 2009

Type 1 Diabetes TrialNet: Clinical Centers (U01)
RFA-DK-08-011
Posted Date: December 24, 2008
Letter of Intent Due Date: February 10, 2009
Application Receipt Date: March 10, 2009

Seeding Collaborative Research in Beta Cell Biology (SCRBCB) Program
This program will provide research support for a limited time (18 months) to enable eligible investigative teams to explore the feasibility of concepts related to the mission of the Beta Cell Biology Consortium. Specific details can be found on the BCBC website at www.betacell.org/seeding/. Research areas open to support through the SCRBCB program are:

  • Generation of humanized mouse models for the assessment and enhancement of human islet regenerative capacity.
  • Production and use of T1D-specific induced pluripotent stem cells (iPSCs).
  • Transdifferentiation or reprogramming of a differentiated cell type into a pancreatic beta-cell.
  • Generation of engineered pancreatic islet-like structures for engraftment.
  • Non-invasive technology for imaging of beta-cell mass in vivo.

 

Request for Proposals: Islet Cell Distribution Coordinating Center
NIH-NIDDK-08-099-SB
Application Receipt Date: 3:00 EST on February 11, 2009

2008

Beta Cell Biology Consortium 2008 Pilot and Feasibility Program
This Pilot and Feasibility Program will provide research support for a limited time (1-2 years) to enable eligible investigators to explore the feasibility of concepts related to the mission of the Beta Cell Biology Consortium (BCBC). Areas of research particularly relevant to the current effort of the consortium include, but are not limited to:

  • production of human beta-cells for cell replacement strategies
  • beta-cell regeneration and regulation of beta-cell mass
  • small molecules or secreted factors controlling beta-cell fate or beta-cell regeneration, or
  • non-invasive imaging of beta-cell mass in vivo

 

Type 1 Diabetes Pathfinder Award (DP2)
RFA-DK-08-001
Posted Date: November 26, 2007
Open Date (Earlierst Submission Date): March 10, 2008
Letter of Intent Due Date: March 13, 2008
Application Receipt Date: April 10, 2008

2007

Limited Competition: The Environmental Determinants of Diabetes in the Youth (TEDDY) study (U01)
RFA-DK-07-500
Posted Date: June 21, 2007
Letter of Intent Due Date: July 27, 2007
Application Receipt Date: August 29, 2007

2006

High-Density Genotyping of Diabetes and Diabetic Complications Sample Collections (R01)
RFA-DK-06-005
Posted Date: December 28, 2005
Letter of Intent Due Date: March 14, 2006
Application Receipt Date: April 12, 2006

Biomarker Development for Diabetic Complications (R21)
RFA-DK-06-004
Posted Date: April 19, 2006
Letter of Intent Due Date: November 13, 2006
Application Receipt Date: December 12, 2006

Cooperative Multicenter Diabetes Research Network for Hypoglycemia Prevention (U10)
RFA-HD-06-020
Posted Date: October 10, 2006
Letter of Intent Due Date: October 23, 2006
Application Receipt Date: November 22, 2006

Non-Human Primate Islet/Kidney Transplantation Tolerance (U01, U19)
RFA-AI-06-018
Posted Date: May 10, 2006
Letter of Intent Due Date: August 22, 2006
Application Receipt Date: September 22, 2006

Biomarkers of Autoimmunity in Type 1 Diabetes (R21)
RFA-DK-06-002
Posted Date: December 28, 2005
Letter of Intent Due Date: March 14, 2006
Application Receipt Date: April 12, 2006

Toward Imaging the Pancreatic Beta Cell in People (R01)
RFA-DK-06-003
Posted Date: December 13, 2005
Letter of Intent Due Date: March 14, 2006
Application Receipt Date: April 12, 2006

2005

Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) and its Complications (SBIR [R43/R44])
RFA-DK-05-016
Posted Date: October 18, 2005
Letter of Intent Due Date: February 15, 2006
Application Receipt Date: March 15, 2006

Small Business Technology Transfer to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) and its Complications (STTR [R41/R42])
RFA-DK-05-015
Posted Date: October 18, 2005
Letter of Intent Due Date: February 15, 2006
Application Receipt Date: March 15, 2006

Human Pancreatic Islet Cell Resources (ICRs)
RFA-RR-05-003
Posted Date: July 18, 2005
Letter of Intent Due Date: December 6, 2005
Application Receipt Date: January 6, 2006

Animal Models of Diabetic Complications Consortium
RFA-DK-05-011
Posted Date: August 17, 2005
Letter of Intent Due Date: October 21, 2005
Application Receipt Date: November 18, 2005

Mouse Metabolic Phenotyping Centers Consortium
RFA-DK-05-008
Posted Date: June 8, 2005
Letter of Intent Due Date: October 14, 2005
Application Receipt Date: November 16, 2005

Administrative Supplements for a Drug Screening Program for Diabetic Complications
NOT-DK-05-017
Posted Date: August 17, 2005
Request Receipt Date: December 1, 2005

Cooperative Study Group for Autoimmune Disease Prevention
RFA-AI-05-026
Posted Date: May 12, 2005
Letter of Intent Due Date: September 12, 2005
Application Receipt Date: October 12, 2005

Incidence, Natural History, and Quality of Life of Diabetes in Youth
RFA-DP-05-069
Posted Date: May 11, 2005
Letter of Intent Due Date: May 25, 2005
Application Receipt Date: June 24, 2005

Beta Cell Regeneration for Diabetes Therapy
RFA-DK-05-007
Posted Date: March 1, 2005
Letter of Intent Due Date: May 22, 2005
Application Receipt Date: June 22, 2005

Preclinical Study of Efficacy in Animal Models of Diabetic Complications
NIH-NIDDK-O5-04
NOT-DK-05-008

Preclinical Study of Efficacy in Animal Models of Type 1 Diabetes
NIH-NIDDK-O5-05
NOT-DK-05-009

2004

Collaborative Studies on Angiogenesis and Diabetic Complications
RFA-DK-04-022 (also see NOT-DK-05-003).
Posted Date: November 3, 2004
Letter of Intent Due Date: February 17, 2005
Application Receipt Date: March 17, 2005

Immunobiology of Xenotransplantation
RFA-AI-04-042 (also see NOT-AI-04-054)
Posted Date: August 6, 2004
Letter of Intent Due Date: October 22, 2004
Application Receipt Date: November 22, 2004

Beta Cell Biology Consortium (U19)
RFA-DK-04-017 (also see NOT-DK-04-016)
Posted Date: June 21, 2004
Letter of Intent Due Date: October 19, 2004
Application Receipt Date: November 19, 2004

Beta Cell Biology Consortium (U01)
RFA-DK-04-018 (also see NOT-DK-04-016)
Posted Date: June 21, 2004
Letter of Intent Due Date: October 19, 2004
Application Receipt Date: November 19, 2004

Cooperative Clinical Islet Transplantation Consortia: Data Coordinating Center
RFA-DK-04-004
Posted Date: December 5, 2003
Letter of Intent Due Date: March 16, 2004
Application Receipt Date: April 13, 2004

Cooperative Clinical Islet Transplantation Consortia: Clinical Centers
RFA-DK-04-005
Posted Date: December 5, 2003
Letter of Intent Due Date: March 16, 2004
Application Receipt Date: April 13, 2004

Progression of Cardiovascular Disease in Type 1 Diabetes
RFA-HL-04-013
Posted Date: December 4, 2003
Letter of Intent Due Date: February 24, 2004
Application Receipt Date: March 24, 2004

2003

Bench to Bedside Research on Type 1 Diabetes and Its Complications
RFA-DK-03-019
Posted Date: August 14, 2003
Letter of Intent Due Date: January 20, 2004
Application Receipt Date: February 20, 2004

Bench to Bedside Research on Type 1 Diabetes and its Complications
RFA-DK-03-001
Posted Date: August 30, 2002
Letter of Intent Due Date: January 29, 2003
Application Receipt Date: February 26, 2003

Hypoglycemia in Patients with Type 1 Diabetes
RFA-DK-03-017
Posted Date: August 14, 2003
Letter of Intent Due Date: January 20, 2004
Application Receipt Date: February 20, 2004

Innovative Partnerships in Type 1 Diabetes Research
RFA-DK-03-015
Posted Date: June 26, 2003
Letter of Intent Due Date: October 16, 2003
Application Receipt Date: November 13, 2003

Pilot and Feasibility Program in Human Islet Biology
RFA-DK-03-021
Posted Date: July 14, 2003
Letter of Intent Due Date: October 20, 2003 and June 20, 2004
Application Receipt Date: November 20, 2003 and July 20, 2004

Proteomics and Metabolomics in Type 1 Diabetes and Its Complications
RFA-DK-03-024
Posted Date: October 24, 2003
Letter of Intent Due Date: February 18, 2004
Application Receipt Date: March 18, 2004

Seeding Collaborative Research in Beta Cell Biology (SCRBCB)
Posted Date: May 29, 2003
Application Receipt Date: October 1, 2003

Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) RFA in Type 1 Diabetes and Its Complications
RFA-DK-03-020
Posted Date: August 28, 2003
Letter of Intent Due Date: January 19, 2004
Application Receipt Date: February 19, 2004

2002

Bench to Bedside Research on Type 1 Diabetes and its Complications
RFA-DK-02-022
Posted Date: October 11, 2001
Letter of Intent Due Date: February 14, 2002
Application Receipt Date: March 14, 2002

Comprehensive Programs in Beta Cell Biology
RFA-DK-02-014
Posted Date: August 14, 2001
Letter of Intent Due Date: February 13, 2002
Application Receipt Date: March 13, 2002

Bioinformatics Integration Support Contract
RFP-NIH-NIAID-DAIT-02-16
Posted Date: November 27, 2001
Application Receipt Date: February 15, 2002

Consortium for Identification of Environmental Triggers of Type 1 Diabetes
RFA-DK-02-029
Posted Date: January 22, 2002
Letter of Intent Due Date: March 5, 2002
Application Receipt Date: April 15, 2002

Data and Biosample Repository
NOT-DK-02-004

Effects of Hypoglycemia on Neuronal and Glial Cell Function
RFA-NS-02-008
Posted Date: August 7, 2001
Letter of Intent Due Date: February 15, 2002
Application Receipt Date: March 15, 2002

Feasibility Projects to test Strategies for Preventing or Slowing the Progression of Diabetic Nephropathy
RFA-DK-02-025
Posted Date: September 17, 2001
Letter of Intent Due Date: January 17, 2002
Application Receipt Date: February 14, 2002

Gene Transfer Approaches to Enhance Islet Transplantation
RFA-DK-02-020
Posted Date: September 20, 2001
Letter of Intent Due Date: November 15, 2001
Application Receipt Date: December 12, 2001

Imaging Early Markers of Diabetic Microvascular Complications in Peripheral Tissue
RFA-DK-02-001
Posted Date: November 26, 2001
Letter of Intent Due Date: February 15, 2002
Application Receipt Date: March 15, 2002

Imaging Pancreatic Beta Cell Mass, Function, Engraftment or Inflammation
RFA-DK-02-002
Posted Date: August 1, 2001
Letter of Intent Due Date: February 15, 2002
Application Receipt Date: March 15, 2002

Innovative Partnerships in Type 1 Diabetes Research
RFA-DK-02-023
Posted Date: October 2, 2001
Letter of Intent Due Date: February 14, 2002
Application Receipt Date: March 14, 2002

Sensor Development and Validation
RFA-EB-02-002
Posted Date: February 25, 2002
Letter of Intent Due Date: March 29, 2002
Application Receipt Date: April 24, 2002

Surrogate Endpoints for Diabetic Microvascular Complications
RFA-DK-02-016
Posted Date: August 30, 2001
Letter of Intent Due Date: January 17, 2002
Application Receipt Date: February 14, 2002

Training Programs in Diabetes Research for Pediatric Endocrinologists
RFA-DK-02-024
Posted Date: October 18, 2001
Letter of Intent Due Date: February 26, 2002
Application Receipt Date: March 26, 2002

2001

Beta Cell Biology Consortium
RFA-DK-01-014
Posted Date: October 11, 2000
Letter of Intent Due Date: March 16, 2001
Application Receipt Date: April 17, 2001

Cooperative Multicenter Research Network to Test Glucose Sensors in Children With Type 1 Diabetes Mellitus
RFA-HD-01-009
Posted Date: February 22, 2001
Letter of Intent Due Date: March 27, 2001
Application Receipt Date: May 11, 2001

Diabetic Macular Edema Clinical Trials Network
RFA-EY-01-001
Posted Date: June 7, 2001
Application Receipt Date: October 26, 2001

Gene Therapy Approaches for Diabetes and Its Complications
RFA-DK-01-006
Posted Date: August 30, 2000
Letter of Intent Due Date: October 16, 2000
Application Receipt Date: November 16, 2000

Human Pancreatic Islet Cell Resources (ICRs)
RFA-RR-01-002
Posted Date: January 3, 2001
Letter of Intent Due Date: February 8, 2001
Application Receipt Date: March 21, 2001

Mouse Models of Diabetic Complications Consortium
RFA-DK-01-009
Posted Date: October 31, 2000
Letter of Intent Due Date: February 28, 2001
Application Receipt Date: March 28, 2001

Non-Mouse Models of Diabetes Complications in Cardiovascular and Microvascular Diseases
RFA-HL-01-010
Posted Date: November 20, 2000
Letter of Intent Due Date: February 26, 2001
Application Receipt Date: March 21, 2001

Non-Human Primate Immune Tolerance Cooperative Study Group
RFA-AI-01-006
Posted Date: January 25, 2001
Letter of Intent Due Date: June 11, 2001
Application Receipt Date: July 17, 2001

Oral Microbiology/Immunology of Type 1 Diabetes
RFA-DE-01-001
Posted Date: January 30, 2001
Letter of Intent Due Date: March 12, 2001
Application Receipt Date: April 12, 2001

Type 1 Diabetes Trialnet: Core Support Facilities
RFA-DK-01-004
Posted Date: October 5, 2000
Letter of Intent Due Date: February 28, 2001
Application Receipt Date: March 29, 2001

Understanding Hypoglycemia Unawareness in Patients with Diabetes
Posted Date: July 27, 2001
RFA-DK-01-031
Letter of Intent Due Date: October 14, 2001
Application Receipt Date: November 21, 2001

2000

Cooperative Study Group for Autoimmune Disease Prevention
RFA-AI-00-016
Posted Date: September 7, 2000
Letter of Intent Due Date: December 15, 2000
Application Receipt Date: February 26, 2001

Innovative Grants on Immune Tolerance
RFA-AI-00-006
Posted Date: February 9, 2000
Letter of Intent Due Date: August 1, 2000
Application Receipt Date: September 14, 2000

New Strategies for the Treatment of Type 1 Diabetes
RFA-DK-00-001
Posted Date: September 30, 1999
Letter of Intent Due Date: March 14, 2000
Application Receipt Date: April 14, 2000

Neurobiology of Diabetic Complications
RFA-NS-00-002
Posted Date: January 13, 2000
Letter of Intent Due Date: March 24, 2000
Application Receipt Date: April 25, 2000

1999

Collaborative Network for Clinical Research on Immune Tolerance
RFP-NIH-NIAID-DAIT-99-30
Posted Date: January 15, 1999
Application Receipt Date: May 14, 1999

Functional Genomics of the Developing Endocrine Pancreas
RFA-DK-99-007
Posted Date: December 4, 1998
Letter of Intent Due Date: February 10, 1999
Application Receipt Date: March 10, 1999

Neurological Complications of Diabetes
RFA-NS-99-005
Posted Date: December 22, 1998
Letter of Intent Due Date: March 16, 1999
Application Receipt Date: April 27, 1999

Pilot Studies for New Therapies for Type 1 Diabetes and its Complications
RFA-DK-99-013
Posted Date: January 8, 1999
Letter of Intent Due Date: March 1, 1999
Application Receipt Date: March 30, 1999

1998

Cellular and Molecular Approaches to Achieving Euglycemia
RFA-DK-98-007
Posted Date: November 21, 1997
Letter of Intent Due Date: February 19, 1998
Application Receipt Date: March 19, 1998

Glucose Sensors in the Treatment of Diabetes
RFA-DK-98-008
Posted Date: November 21, 1997
Letter of Intent Due Date: February 19, 1998
Application Receipt Date: March 19, 1998

Immunopathogenesis of Type 1 Diabetes
RFA-DK-98-010
Posted Date: November 21, 1997
Letter of Intent Due Date: February 19, 1998
Application Receipt Date: March 19, 1998

Pathogenesis and Therapy of Complications of Diabetes
RFA-DK-98-009
Posted Date: November 21, 1997
Letter of Intent Due Date: February 19, 1998
Application Receipt Date: March 19, 1998